Frankfurt - Delayed Quote EUR
Telix Pharmaceuticals Limited (T3X.F)
16.89
+1.09
+(6.93%)
As of 4:56:36 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
49,706
43,029
23,884
-63,970
-59,328
Investing Cash Flow
-68,444
-135,173
-25,489
-16,997
-2,726
Financing Cash Flow
7,638
638,923
10,186
174,960
2,846
End Cash Position
120,629
710,346
123,237
116,329
22,037
Income Tax Paid Supplemental Data
11,179
--
10,253
2,278
--
Interest Paid Supplemental Data
1,406
--
785
131
189
Capital Expenditure
-28,401
-34,032
-10,794
-13,861
-1,339
Issuance of Capital Stock
4,358
999
6,652
181,039
3,782
Issuance of Debt
5,972
655,938
5,756
3,014
--
Repayment of Debt
--
-3,130
-2,222
-1,277
-340
Repurchase of Capital Stock
--
--
--
-7,816
--
Free Cash Flow
21,305
8,997
13,090
-77,831
-60,667
12/31/2021 - 7/17/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ASPHF Ascentage Pharma Group International
5.83
-9.69%
BEAM.MX Beam Therapeutics Inc.
320.00
-14.52%
ADAG Adagene Inc.
1.3900
-2.80%
AAPG Ascentage Pharma Group Internat
25.50
+6.68%
BCTXW BriaCell Therapeutics Corp.
0.1700
+36.06%
SER Serina Therapeutics, Inc.
6.06
+4.84%
RNTX Rein Therapeutics Inc.
1.7900
-1.65%
MBX MBX Biosciences, Inc.
9.25
+2.89%
DSGN Design Therapeutics, Inc.
4.1150
+1.11%
BCAX Bicara Therapeutics Inc.
15.39
-0.77%